Search bioRxiv⌕ Search
Home/Archive/bioRxiv

bioRxiv · 10.64898/2026.04.12.718057

Discovery of Selective Nrf2 Activators from Natural Products: AComputational Screening Approach to Minimize Off-Target Effects on PXR and CYP2D6

Wang, Y.·Gong, Y.·Li, R.·Li, Z.·Cai, H.·Fan, L.·Ma, H.
View original source ↗Export metadata ↓

Abstract

Nuclear factor erythroid 2-related factor 2 (Nrf2) is a central regulator of cellular antioxidant responses and a highly promising therapeutic target for a range of oxidative stress-related diseases. However, the clinical translation of Nrf2 activators has been hampered by significant off-target effects--notably unintended activation of the pregnane X receptor (PXR) and inhibition of cytochrome P450 2D6 (CYP2D6)--which can lead to dangerous drug-drug interactions and metabolic complications. To overcome this critical barrier, we conducted the first large-scale computational screening of 628,898 natural products from the COCONUT database, integrating molecular docking with a rigorous three-tier selectivity strategy designed to prioritize compounds that strongly bind KEAP1 (the primary Nrf2 repressor) while minimizing interactions with PXR and CYP2D6. Our innovative approach identified 10 ultraselective candidates that demonstrate potent KEAP1 affinity, negligible PXR engagement, and only moderate CYP2D6 binding--achieving up to 12.29-fold selectivity for Nrf2 pathway activation. These top hits are structurally novel, enriched in lipid-like and nucleoside-inspired scaffolds, and exhibit promising drug-like properties. By providing both a curated set of chemically diverse, selectivity-optimized leads and a publicly accessible screening dataset, this work establishes a new foundation for the rational development of safer, more precise Nrf2-targeted therapies, bridging a crucial gap between target potential and clinical viability. By prioritizing compounds with minimal off-target effects on PXR and CYP2D6, our approach offers a scalable template for reducing drug development failures and advancing safer therapeutics for oxidative stress-related diseases. O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=124 SRC="FIGDIR/small/718057v1_ufig1.gif" ALT="Figure 1"> View larger version (26K): org.highwire.dtl.DTLVardef@13c6c79org.highwire.dtl.DTLVardef@1f5a078org.highwire.dtl.DTLVardef@fa4f4borg.highwire.dtl.DTLVardef@16bc881_HPS_FORMAT_FIGEXP M_FIG O_FLOATNOGraphical abstractC_FLOATNO C_FIG

Explore related subjects

bioinformaticsPreprint

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Wang, Y., Gong, Y., Li, R., Li, Z., Cai, H., Fan, L., Ma, H.. 2026-04-15. Discovery of Selective Nrf2 Activators from Natural Products: AComputational Screening Approach to Minimize Off-Target Effects on PXR and CYP2D6. https://doi.org/10.64898/2026.04.12.718057

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2026

Targeted finetuning enables co-folding models to learn ligand-induced protein conformational states

Advances in protein structure prediction have enabled all-atom protein-ligand co-folding models that predict bound conformations directly from sequence and small-molecule structure. However, these models often fail to generalize to novel binding sites or alternative protein conformational states, limiting their utility for chemical biology and drug discovery. Here we show this limitation reflects training data bias rather than architectural constraints and can be overcome through targeted finetuning. Using ten previously unseen X-ray structures of Werner (WRN) helicase from a drug discovery program, we finetune Boltz-1 to learn both an allosteric binding site and a large conformational change locking the enzyme in an inactive state, while preserving accuracy on the ATP-bound state. The finetuned model generalizes to different chemical series and transfers the conformational logic across RecQ-family helicases in a binding-site sequence-dependent manner. This approach provides a blueprint for adapting foundation models as new structural and mechanistic data emerge, enabling co-folding networks to capture ligand-induced conformational switches and binding poses absent from their training data but central to biological regulation and therapeutic intervention.

bioinformatics↗
bioRxiv2026

Benchmarking single-cell foundation models for aging biology

Single cell foundation models (scFMs) provide representations of cellular states, but their utility across biological questions in aging research remains unclear. We established a benchmark of cellular representations for aging research, evaluating ten general-purpose scFMs, three aging-specific models and conventional methods across five biological questions using more than 2.5 million single cell transcriptomes. Using frozen pretrained representations, Geneformer performed best among scFMs for chronological age prediction and age pseudotime concordance, although 2,000 highly variable genes achieved higher mean performance. Several scFMs captured positive molecular age shifts across three disease contexts, consistent with reported aging-associated changes. SCimilarity performed well for rare cellular state identification across out-of-distribution datasets, exceeding aging specific models and conventional baselines. At the gene level, scGPT showed the highest recovery of reference TF target interactions, including aging-related regulatory hubs. Overall, scFMs supported diverse aging analyses, but performance depended on the biological question, highlighting their utility for rare cellular state identification and regulatory analysis.

bioinformatics↗
bioRxiv2026

CryoMV: Structure-Prior-Guided Modeling and Real-Particle Validation of Continuous Conformational Transitions in Cryo-EM

Continuous protein conformations are essential for understanding fundamental biological processes and supporting drug discovery. Although cryo-EM can resolve individual states at high resolution, recovering continuous heterogeneity from 2D particle images remains challenging. High noise, motion blur, and limited structural priors make it difficult to accurately generate and validate high-resolution continuous conformations using raw particle data. Here, we introduce cryoMV, a framework that integrates structure-prior-guided modeling with real-particle validation for continuous conformational transitions. CryoMV uses reference density maps to establish structural anchors and motion priors, models candidate transition paths between selected conformations, and transfers the learned representation to raw 2D cryo-EM particle images. Each candidate conformation is subsequently evaluated using the estimated particle poses and contrast transfer functions. Supported conformations are reconstructed through raw particle back-projection and assessed using canonical half-maps and Fourier shell correlation. On EMPIAR-10516 and EMPIAR-10345, cryoMV achieves excellent performance in terms of robustness, verifiability, and reconstruction resolution. By incorporating structure-prior modeling and evidence from the raw particles, cryoMV offers an explicit mechanism for assessing whether generated conformations are supported by experimental data and provides a practical approach to reducing model-induced artifacts in continuous cryo-EM heterogeneity analysis.

bioinformatics↗